This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Aractingi S, Chosidow O . Cutaneous graft-versus-host disease. Arch Dermatol 1998; 134: 602–612.
Casper J, Knauf W, Kiefer T, Wolff D, Steiner B, Hammer U et al. Treosulfan and fludarabine: a new toxicity-reduced conditioning regimen for allogeneic hematopoietic stem cell transplantation. Blood 2004; 103: 725–731.
Bearman SI, Appelbaum FR, Buckner CD, Petersen FB, Fisher LD, Clift RA et al. Regimen-related toxicity in patients undergoing bone marrow transplantation. J Clin Oncol 1988; 6: 1562–1568.
Glucksberg H, Storb R, Fefer A, Buckner CD, Neiman PE, Clift RA et al. Clinical manifestations of graft-versus-host disease in human recipients of marrow from HL-A-matched sibling donors. Transplantation 1974; 18: 295–304.
Buechner SA . Rosacea: an update. Dermatology 2005; 210: 100–108.
Powell FC . Rosacea and the pilosebaceous follicle. Cutis 2004; 74 (Suppl 3): 9–12.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Lotze, C., Krüger, W., Kiefer, T. et al. Facial rash mimicking cutaneous acute graft-versus-host disease after allogeneic stem cell transplantation for osteomyelofibrosis – was Demodex the culprit?. Bone Marrow Transplant 37, 711–712 (2006). https://doi.org/10.1038/sj.bmt.1705296
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1705296